Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) FCF Margin: 2010-2025

Historic FCF Margin for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to 12.28%.

  • OptimizeRx's FCF Margin rose 42300.0% to 12.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.62%, marking a year-over-year increase of 117800.0%. This contributed to the annual value of 4.94% for FY2024, which is 161600.0% up from last year.
  • Latest data reveals that OptimizeRx reported FCF Margin of 12.28% as of Q3 2025, which was up 42300.0% from 15.51% recorded in Q2 2025.
  • OptimizeRx's FCF Margin's 5-year high stood at 29.61% during Q1 2022, with a 5-year trough of 19.32% in Q4 2023.
  • For the 5-year period, OptimizeRx's FCF Margin averaged around 5.63%, with its median value being 3.94% (2024).
  • As far as peak fluctuations go, OptimizeRx's FCF Margin skyrocketed by 641600bps in 2021, and later plummeted by -330800bps in 2023.
  • OptimizeRx's FCF Margin (Quarter) stood at 8.05% in 2021, then soared by 271bps to 13.76% in 2022, then plummeted by -240bps to 19.32% in 2023, then soared by 102bps to 0.29% in 2024, then skyrocketed by 4079bps to 12.28% in 2025.
  • Its FCF Margin stands at 12.28% for Q3 2025, versus 15.51% for Q2 2025 and 17.36% for Q1 2025.